Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
miR-3065-5p-responsive messenger RNAs (mRNAs) are a collection of transcripts whose expression levels are controlled by the microRNA miR-3065-5p. This regulation occurs through the binding of the microRNA to complementary sequences, usually within the 3' untranslated region (UTR) of the target mRNAs (Source: PubMed ID 31480385). Once bound, the microRNA-induced silencing complex (miRISC) promotes mRNA degradation or prevents the translation of the mRNA into a functional protein. Validated responsive mRNAs for miR-3065-5p include those for CXCL12, SOX2, and YAP1, which are involved in critical pathways like cell growth and epithelial-mesenchymal transition (Source: PubMed ID 26109430, 30106431). In various malignancies, such as osteosarcoma and glioma, miR-3065-5p is frequently downregulated, leading to the overexpression of these responsive mRNAs and subsequent tumor progression. Therapeutic strategies aim to restore miR-3065-5p levels using synthetic mimics to downregulate these oncogenic mRNAs. However, the primary challenge in targeting these mRNAs collectively is the inherent lack of specificity, as a single microRNA can influence hundreds of different genes. This broad regulatory reach increases the risk of off-target effects in healthy tissues, complicating the development of safe and effective miRNA-based therapies.
MicroRNA-mediated gene silencing via 3' UTR binding, leading to mRNA degradation or translational repression.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-3065-5p-responsive messenger RNAs (miR-3065-5p targets).